Sandhya Girish

8PUBLICATIONS
29CO-AUTHORS
GlycoconjugatesRegenerative medicine (incl. stem cells)Medical virologyCancer therapy (excl. chemotherapy and radiation therapy)Pharmacogenomics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Mar 19, 2026
Pharmacokinetics, Safety, and Tolerability of GS-1427, an Oral Prodrug of a Potent and Selective α4β7 Integrin Inhibitor, in Healthy Participants.

Jin Zhou, Neeraja Maramreddy, John McFarlane

|Jul 14, 2025
Sacituzumab Govitecan Population Pharmacokinetics: Updated Analyses Using HR+/HER2- Metastatic Breast Cancer Data From the Phase 3 TROPiCS-02 Trial.

Abhishek G Sathe, Aksana K Jones, Paul M Diderichsen

|Feb 21, 2025
Modeling the Interplay Between Viral and Immune Dynamics in HIV: A Review and Mrgsolve Implementation and Exploration.

Alberto Vegas Rodriguez, Nieves Velez de Mendizábal, Sandhya Girish

|Nov 15, 2024
Exposure-Response Analyses of Sacituzumab Govitecan Efficacy and Safety in Patients With Metastatic Triple-Negative Breast Cancer.

Abhishek G Sathe, Paul M Diderichsen, Floris Fauchet

|Sep 09, 2023
Pharmacokinetics, safety, and tolerability of inhaled remdesivir in healthy participants.

Rita Humeniuk, Kavita Juneja, Shuguang Chen

|Jun 09, 2021
Population pharmacokinetic and exploratory exposure-response analysis of the fixed-dose combination of pertuzumab and trastuzumab for subcutaneous injection in patients with HER2-positive early breast cancer in the FeDeriCa study.

Bei Wang, Rong Deng, Stefanie Hennig

Pageof 2

Frequent Collaborators

2 joint publications

Bei Wang

2 joint publications

Rong Deng

2 joint publications

Stefanie Hennig

2 joint publications

Tanja Badovinac Crnjevic